Differential expression of transcription factors predicted to regulate angiopoietin-1 and -2 genes is associated with specific angiopoietin signatures in RA and PsA synovial tissue von Frleta, M, van Baarsen, LGM, Garcia-Perez, S, de Launay, D, Garrelfs, M, Gerlag, DM, Tak, PP, Reedquist, KA

Volltext

Tangiopoietins-1 and -2 are differentially regulated and make distinct contributions to synovial Tie2 activation in patients with rheumatoid arthritis and psoriatic arthritis von Frleta, M, van Baarsen, L G M, de Launay, D, Garrelfs, M, Gerlag, D M, Tak, P P, Reedquist, K A

Volltext

Tumor-associated reactive astrocytes aid the evolution of immunosuppressive environment in glioblastoma von Henrik Heiland, Dieter, Ravi, Vidhya M., Behringer, Simon P., Frenking, Jan Hendrik, Wurm, Julian, Joseph, Kevin, Garrelfs, Nicklas W. C., Strähle, Jakob, Heynckes, Sabrina, Grauvogel, Jürgen, Franco, Pamela, Mader, Irina, Schneider, Matthias, Potthoff, Anna-Laura, Delev, Daniel, Hofmann, Ulrich G., Fung, Christian, Beck, Jürgen, Sankowski, Roman, Prinz, Marco, Schnell, Oliver

Volltext

Lumasiran, an RNAi Therapeutic for Primary Hyperoxaluria Type 1 von Garrelfs, Sander F, Frishberg, Yaacov, Hulton, Sally A, Koren, Michael J, O’Riordan, William D, Cochat, Pierre, Deschênes, Georges, Shasha-Lavsky, Hadas, Saland, Jeffrey M, van’t Hoff, William G, Fuster, Daniel G, Magen, Daniella, Moochhala, Shabbir H, Schalk, Gesa, Simkova, Eva, Groothoff, Jaap W, Sas, David J, Meliambro, Kristin A, Lu, Jiandong, Sweetser, Marianne T, Garg, Pushkal P, Vaishnaw, Akshay K, Gansner, John M, McGregor, Tracy L, Lieske, John C

Volltext

Cyclooxygenase (COX) Inhibition by Acetyl Salicylic Acid (ASA) Enhances Antitumor Effects of Nitric Oxide in Glioblastoma In Vitro von Guenzle, Jessica, Garrelfs, Nicklas W. C., Goeldner, Jonathan M., Weyerbrock, Astrid

Volltext

Lumasiran, an RNAi Therapeutic for Primary Hyperoxaluria Type 1. Reply von Garrelfs, Sander F, Gansner, John M, Lieske, John C

Volltext

Application of four pricing models for orphan medicines: a case study for lumasiran von Rosenberg, Noa, Manders, Evert, van den Berg, Sibren, Deesker, Lisa J, Garrelfs, Sander F, de Visser, Saco J, Groothoff, Jaap W, Hollak, Carla E M

Volltext

Inhibition of metabotropic glutamate receptor III facilitates sensitization to alkylating chemotherapeutics in glioblastoma von Maier, Julian P., Ravi, Vidhya M., Kueckelhaus, Jan, Behringer, Simon P., Garrelfs, Niklas, Will, Paulina, Sun, Na, von Ehr, Jasmin, Goeldner, Jonathan M., Pfeifer, Dietmar, Follo, Marie, Hannibal, Luciana, Walch, Axel Karl, Hofmann, Ulrich G., Beck, Jürgen, Heiland, Dieter Henrik, Schnell, Oliver, Joseph, Kevin

Volltext

Glycolate oxidase inhibition by lumasiran varies between patients with primary hyperoxaluria type 1 von Garrelfs, Sander F., Metry, Elisabeth L., van Harskamp, Dewi, Vaz, Frederic M., van den Akker, Chris H.P., Schierbeek, Henk, Groothoff, Jaap W., Oosterveld, Michiel J.S.

Volltext

Successful kidney-alone transplantation in a patient with PH1 on combination RNA-interference therapy von Metry, Elisabeth L., Deesker, Lisa J., Garrelfs, Sander F., Oosterveld, Michiel J.S., Beekman, Kerensa M., Cornelissen, Marlies E.A., Koster-Kamphuis, Linda, Groothoff, Jaap W.

Volltext

Corrigendum to “Successful kidney-alone transplantation in a patient with PH1 on combination RNA-interference therapy.” Kidney International, 2023;104:203–204 von Metry, Elisabeth L., Deesker, Lisa J., Garrelfs, Sander F., Oosterveld, Michiel J.S., Beekman, Kerensa M., Cornelissen, Elisabeth A.M., Koster-Kamphuis, Linda, Groothoff, Jaap W.

Volltext

Plasma oxalate and glycolate concentrations in dialysis patients with and without primary hyperoxaluria type 1 von Metry, Elisabeth L, Garrelfs, Sander F, Peters-Sengers, Hessel, Vaz, Frederic M, Bijlsma, Joost A, Neradova, Aegida, Oosterveld, Michiel J S, Groothoff, Jaap W

Volltext

Transplantation outcomes in patients with primary hyperoxaluria: a systematic review von Metry, Elisabeth L., van Dijk, Liza M. M., Peters-Sengers, Hessel, Oosterveld, Michiel J.S., Groothoff, Jaap W., Ploeg, Rutger J., Stel, Vianda S., Garrelfs, Sander F.

Volltext

The retinal phenotype in primary hyperoxaluria type 2 and 3 von Birtel, Johannes, Diederen, Roselie M., Herrmann, Philipp, Kaspar, Sophie, Beck, Bodo B., Garrelfs, Sander F., Hoppe, Bernd, Charbel Issa, Peter

Volltext

The Ocular Phenotype in Primary Hyperoxaluria Type 1 von Birtel, Johannes, Herrmann, Philipp, Garrelfs, Sander F., Dulz, Simon, Atiskova, Yevgeniya, Diederen, Roselie M., Gliem, Martin, Brinkert, Florian, Holz, Frank G., Boon, Camiel J.F., Hoppe, Bernd, Charbel Issa, Peter

Volltext

[ 18 F]NaF PET/CT as a Marker for Fibrodysplasia Ossificans Progressiva: From Molecular Mechanisms to Clinical Applications in Bone Disorders von Zwama, Jolien, Rosenberg, Neeltje M, Verheij, Vincent A, Raijmakers, Pieter G H M, Yaqub, Maqsood, Botman, Esmée, de Ruiter, Ruben D, Garrelfs, Mark R, Bökenkamp, Arend, Micha, Dimitra, Schwarte, Lothar A, Teunissen, Bernd P, Lammertsma, Adriaan A, Boellaard, Ronald, Eekhoff, Elisabeth M W

Volltext

Randomized Clinical Trial on the Long-Term Efficacy and Safety of Lumasiran in Patients With Primary Hyperoxaluria Type 1 von Hulton, Sally A., Groothoff, Jaap W., Frishberg, Yaacov, Koren, Michael J., Overcash, J. Scott, Sellier-Leclerc, Anne-Laure, Shasha-Lavsky, Hadas, Saland, Jeffrey M., Hayes, Wesley, Magen, Daniella, Moochhala, Shabbir H., Coenen, Martin, Simkova, Eva, Garrelfs, Sander F., Sas, David J., Meliambro, Kristin A., Ngo, Taylor, Sweetser, Marianne T., Habtemariam, Bahru A., Gansner, John M., McGregor, Tracy L., Lieske, John C.

Volltext

Lumasiran, an RNAi Therapeutic for Primary Hyperoxaluria Type 1 von Shah, Viral N, Pyle, Laura, Garrelfs, Sander F, Gansner, John M, Lieske, John C

Volltext

Eculizumab in Pediatric Dense Deposit Disease von Oosterveld, Michiel J S, Garrelfs, Mark R, Hoppe, Bernd, Florquin, Sandrine, Roelofs, Joris J T H, van den Heuvel, L P, Amann, Kerstin, Davin, Jean-Claude, Bouts, Antonia H M, Schriemer, Pietrik J, Groothoff, Jaap W

Volltext

ATF3 reduces migration capacity by regulation of matrix metalloproteinases via NFκB and STAT3 inhibition in glioblastoma von Guenzle, Jessica, Wolf, Louisa J, Garrelfs, Nicklas W C, Goeldner, Jonathan M, Osterberg, Nadja, Schindler, Cora R, Saavedra, Joseph E, Weyerbrock, Astrid

Volltext